
Jingsong Zhang, MD, PhD, discusses the current state of risk stratification in metastatic castration-resistant prostate cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: August 30th 2021 | Updated:

Published: October 7th 2016 | Updated: